메뉴 건너뛰기




Volumn 20, Issue 24, 2010, Pages 7454-7457

Diamino-1,2,4-triazole derivatives are selective inhibitors of TYK2 and JAK1 over JAK2 and JAK3

Author keywords

JAK1; JAK2; JAK3; Janus associated kinase; TYK2; Tyrosine kinase 2

Indexed keywords

4 [N [1 (2 CYANO 1 OXOETHYL) 4 METHYL 3 PIPERIDINYL] N METHYLAMINO]PYRROLO[2,3 D]PYRIMIDINE; GAMMA INTERFERON; INCB 018424; JANUS KINASE 1; JANUS KINASE 2; JANUS KINASE 3; JANUS KINASE INHIBITOR; JNJ 7706621; TG 101348; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

EID: 78449283839     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.10.026     Document Type: Article
Times cited : (35)

References (19)
  • 11
    • 78449270864 scopus 로고    scopus 로고
    • U.S. Patent Application 2009/0286789
    • Hood, J. D.; Noronha, G. U.S. Patent Application 2009/0286789.
    • Hood, J.D.1    Noronha, G.2
  • 13
    • 78449289917 scopus 로고    scopus 로고
    • Rodgers J. D.; Wang H.; Combs A. P.; Sparks R. B. U.S. Patent 7335667
    • Rodgers, J. D.; Wang, H.; Combs, A. P.; Sparks, R. B. U.S. Patent 7335667, 2008.
    • (2008)
  • 15
    • 78449304127 scopus 로고    scopus 로고
    • Fridman, J. S. Presented at Cambridge Healthtech Institute's Fifth Annual Drug Discovery Chemistry Meeting, San Diego, CA, April 2010; Development of a JAK-inhibitor for Rheumatoid Arthritis
    • Fridman, J. S. Presented at Cambridge Healthtech Institute's Fifth Annual Drug Discovery Chemistry Meeting, San Diego, CA, April 2010; Development of a JAK-inhibitor for Rheumatoid Arthritis.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.